FitLife Brands (FTLF) Competitors

FitLife Brands (NASDAQ:FTLF) and aTyr Pharma (NASDAQ:ATYR) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, media sentiment, valuation, profitability, dividends, community ranking and institutional ownership.

Which has preferable valuation and earnings, FTLF or ATYR?

FitLife Brands has higher revenue and earnings than aTyr Pharma. aTyr Pharma is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FitLife Brands	$64.47M	1.89	$8.98M	$0.84	15.46
aTyr Pharma	$230K	1,927.04	-$64.02M	-$0.81	-6.15

Does the MarketBeat Community believe in FTLF or ATYR?

aTyr Pharma received 13 more outperform votes than FitLife Brands when rated by MarketBeat users. Likewise, 100.00% of users gave aTyr Pharma an outperform vote while only 50.00% of users gave FitLife Brands an outperform vote.

Company	Underperform	Outperform
FitLife Brands	Outperform Votes 3 50.00%	Underperform Votes 3 50.00%
aTyr Pharma	Outperform Votes 16 100.00%	Underperform Votes No Votes

Which has more risk and volatility, FTLF or ATYR?

FitLife Brands has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500. Comparatively, aTyr Pharma has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500.

Do analysts prefer FTLF or ATYR?

FitLife Brands presently has a consensus price target of $20.50, indicating a potential upside of 57.81%. aTyr Pharma has a consensus price target of $20.20, indicating a potential upside of 305.62%. Given aTyr Pharma's higher probable upside, analysts plainly believe aTyr Pharma is more favorable than FitLife Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FitLife Brands	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33
aTyr Pharma	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	3.14

Do institutionals & insiders have more ownership in FTLF or ATYR?

2.3% of FitLife Brands shares are held by institutional investors. Comparatively, 61.7% of aTyr Pharma shares are held by institutional investors. 61.3% of FitLife Brands shares are held by insiders. Comparatively, 3.7% of aTyr Pharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Is FTLF or ATYR more profitable?

FitLife Brands has a net margin of 13.85% compared to aTyr Pharma's net margin of 0.00%. FitLife Brands' return on equity of 25.59% beat aTyr Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FitLife Brands	13.85%	25.59%	15.26%
aTyr Pharma	N/A	-87.09%	-64.77%

Does the media refer more to FTLF or ATYR?

In the previous week, aTyr Pharma had 5 more articles in the media than FitLife Brands. MarketBeat recorded 6 mentions for aTyr Pharma and 1 mentions for FitLife Brands. aTyr Pharma's average media sentiment score of 0.87 beat FitLife Brands' score of 0.47 indicating that aTyr Pharma is being referred to more favorably in the news media.

Company	Overall Sentiment
FitLife Brands	Neutral
aTyr Pharma	Positive

Summary

FitLife Brands and aTyr Pharma tied by winning 9 of the 18 factors compared between the two stocks.